EGFR and neoplasm: LiTE-containing mouse serum collected at 4 hours and 4 days after LiTERNA-LNP i.v. administration mediated EGFR-specific cytotoxicity of CT26EGFR tumor cells ex vivo, indicating full functionality of the antibody produced in vivo (dashed blue line) (Figure 3D).